+Compare
ACET
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
865.17M

ACET Price Prediction, Adicet Bio AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
ACET Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Dec 05, 2022

ACET in +8.67% Uptrend, rising for three consecutive days on December 05, 2022

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ACET advanced for three days, in 236 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 01, 2022. You may want to consider a long position or call options on ACET as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ACET just turned positive on December 05, 2022. Looking at past instances where ACET's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 178 cases where ACET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ACET moved out of overbought territory on November 15, 2022. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ACET broke above its upper Bollinger Band on November 10, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ACET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.723) is normal, around the industry mean (25.700). P/E Ratio (6.061) is within average values for comparable stocks, (74.007). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.828). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (25.773) is also within normal values, averaging (313.544).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

ACET is expected to report earnings to fall 47.55% to -27 cents per share on March 09

Adicet Bio ACET Stock Earnings Reports
Q4'22
Est.
$-0.28
Q3'22
Est.
$-0.53
Q2'22
Missed
by $0.11
Q1'22
Beat
by $0.28
Q4'21
Missed
by $0.05
The last earnings report on November 08 showed earnings per share of -52 cents, beating the estimate of -53 cents. With 639.07K shares outstanding, the current market capitalization sits at 865.17M.
AI
A.I.Advisor
published Dividends

ACET paid dividends on October 09, 2018

Adicet Bio ACET Stock Dividends
А quarterly dividend of $0.01 per share was paid with a record date of October 09, 2018, and an ex-dividend date of September 21, 2018. Read more...
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics (NASDAQ:SRNE).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.92B. The market cap for tickers in the group ranges from 160 to 287.41B. NONOF holds the highest valuation in this group at 287.41B. The lowest valued company is CDXI at 160.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 171%. PVCT experienced the highest price growth at 141%, while AGLE experienced the biggest fall at -63%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -3%. For the same stocks of the Industry, the average monthly volume growth was -42% and the average quarterly volume growth was -85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 84
Price Growth Rating: 60
SMR Rating: 92
Profit Risk Rating: 94
Seasonality Score: 23 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

a distributor of pharmaceutical intermediate ingrediants and other industrial chemicals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Distributors
Address
200 Clarendon Street
Phone
+1 650 503-9095
Employees
102
Web
https://www.adicetbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUARX11.37-0.13
-1.13%
Pioneer Flexible Opportunities R
MRLBX5.39-0.08
-1.46%
Morgan Stanley Inst Global Real Est A
TWQZX13.26-0.25
-1.85%
Transamerica Large Cap Value I2
WFMDX48.17-0.99
-2.01%
Allspring Special Mid Cap Value Admin
PISMX9.14-0.19
-2.04%
Principal International Sml Compny Instl

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with INSM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+4.83%
INSM - ACET
58%
Loosely correlated
-2.36%
IBRX - ACET
58%
Loosely correlated
-5.46%
GRPH - ACET
54%
Loosely correlated
+2.57%
KRYS - ACET
54%
Loosely correlated
-2.22%
ARWR - ACET
54%
Loosely correlated
-6.22%
More